If your child struggles with their vision, focus, or eye control, they might also have low self-esteem due to the way their condition is being perceived by others. Your child’s doctor or ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

New Vision Therapy, PLLC is made up of a variety of therapists using numerous therapeutic approaches. We work with adolescents and adults in individual, group, and family therapeutic sessions. If you ...

Age-related macular degeneration (AMD) gradually affects central vision in one or both eyes while leaving peripheral vision (on the sides) intact. This peripheral vision – encompassing everything you ...

Please provide your email address to receive an email when new articles are posted on . Optometrists sometimes suggest vision therapy to improve visual skills, addressing perceptual vision and myopia.

When it comes to the health and wellbeing of a child, parents will do just about anything. Paul Bresge started a biotech company. Bresge’s middle daughter, Tamar, was young when her eye problems ...

This ocular condition happens as the result of a slight eye misalignment, which can cause symptoms such as dizziness and blurry vision. Treatment includes specialty lenses and vision therapy. Share on ...

If a teacher says that a child is struggling to pay attention in class, the quick conclusion might be to get them tested for ADHD. A Bethesda-based neuro-optometrist says it might be something else: ...

Please provide your email address to receive an email when new articles are posted on . Clinical signs and symptoms were improved after 12 weeks of therapy compared with 6 weeks of observation.

Do you have a passion for helping adults who are blind or visually impaired? We designed this program with you in mind. We prepare vision professionals to advance their careers though additional ...

A Johnson & Johnson gene therapy in development for an inherited vision-loss disorder has failed a Phase 3 study, the latest clinical research setback for a rare eye disease that so far has no ...